Sexual reproduction relies on meiosis, the specialized cell division that produces haploid gametes, such as sperm and eggs, from diploid progenitors. During fertilization, gametes fuse to restore diploidy to the resulting embryo. Errors in meiotic chromosome segregation can have disastrous consequences for embryonic development: The production of gametes with an incorrect number of chromosomes (also referred to as aneuploidy) will produce aneuploid embryos, which are often inviable. Indeed, it is estimated that one-third of human miscarriages are the consequence of defects in meiotic chromosome segregation [1] . Some aneuploidy can be tolerated by the developing embryo but will result in developmental disorders, such as Down and Klinefelter's syndromes. Therefore, understanding the mechanisms that underlie proper chromosome segregation during meiosis will provide useful information about errors that can contribute to human infertility and birth defects.
Checkpoints prevent aneuploidy by responding to defects during both mitotic and meiotic cell cycles. These surveillance mechanisms either halt the cell cycle to provide additional time for repair or activate apoptosis to remove damaged cells. In almost all animals in which meiosis has been studied, only one of the four products of meiosis becomes an egg during female meiosis (oogenesis). Therefore, one would expect that there would be stricter quality control mechanisms to ensure that this single meiotic product has the correct number of chromosomes. However, work on mammalian meiosis suggests that oogenesis has less stringent checkpoint control than male meiosis (spermatogenesis), in which all four meiotic products are capable of fertilization. Many mutations that result in complete sterility in males can lead to a variety of phenotypes in females, including fertility, sub-fertility and infertility [2] . If fertility is affected, the mutant oocytes often progress further in meiosis than their male counterparts before undergoing apoptosis [2] . These findings provide a potential explanation for the high rate of aneuploidy observed during human oogenesis (up to 20%) in comparison to spermatogenesis (3-4%) [3] . Why this difference exists is an open and intriguing question.
In Caenorhabditis elegans, oogenesis appears to be under tighter checkpoint control. As in mice, meiotic checkpoint activation in worms results in culling of defective nuclei by germline apoptosis [4] but apoptosis is limited to oogenesis [5] . This raises the question of whether defects in spermatogenesis are monitored at all. A study from Engebrecht and colleagues reported in this issue of Current Biology nicely addresses this issue [6] . Using an array of previously characterized cytological markers of DNA damage checkpoint activation, the authors illustrate that male meiotic nuclei are as fully capable of activating this checkpoint in response to defects in meiosis as oocytes ( Figure 1 ). They observe recruitment of DNA damage sensors HUS-1 (a member of the 9-1-1 complex) and ATL-1 (the phosphatidylinositol 3-related protein kinase ATR ortholog) to chromatin in meiotic nuclei that have been irradiated or have recombination defects. Moreover, irradiated or mutant males also exhibit phosphorylation of the effector kinase CHK-1, indicating that the recruitment of HUS-1 and ATL-1 to sites of damage is successfully transduced to an effector of the checkpoint. In other systems, ATR-mediated phosphorylation of CHK-1 has been shown to impinge upon cell cycle arrest, repair and regulation of apoptosis [7] .
The authors attribute the absence of apoptosis in response to damage in males to an inability to activate the CED-3 caspase. Upstream events that activate apoptosis, namely CEP-1-mediated upregulation of the proapoptotic genes egl-1 and ced-13 [8] , occur under checkpoint-activating conditions in males and members of the core apoptotic machinery (CED-4 and CED-3) are expressed. How caspase activity is blocked in the male germline is unknown and likely the focus of additional studies.
Why CEP-1, the C. elegans p53 homolog [9, 10] , would activate transcription of egl-1 and ced-13 when apoptosis is blocked further downstream is perplexing. Transcriptional analysis has shown that CEP-1 has only three transcriptional targets in response to DNA damage: egl-1, ced-13 and a novel gene that appears to play no role in the DNA damage checkpoint [11] . Therefore, it is unlikely egl-1 and ced-13 expression is an inadvertent consequence of CEP-1's requirement to upregulate another target required for repair. The authors point out that a similar response occurs in proliferating germline nuclei, in which the DNA damage response produces cell cycle arrest without activating apoptosis [4, 12] , and speculate that these genes may have additional roles.
Despite the inability to cull defective nuclei via apoptosis, the authors nonetheless find that a functional DNA damage checkpoint contributes to genomic stability. In the absence of the checkpoint, males with defects in meiosis produce more inviable, aneuploid progeny. Thus, the authors show that there are actually no sex-specific differences in checkpoint activation, just in the outcome of checkpoint activation: Gamete quality and genomic integrity in male worms are maintained through repair of DNA damage instead of removal of defective nuclei during spermatogenesis.
Does something similar happen during mammalian oogenesis? The analogy is imperfect since apoptosis can occur during oogenesis in mice.
Mutations that produce sterile males may exhibit a range of phenotypes in females because the DNA damage checkpoint favors repair of errors over apoptosis, producing some oocytes that can progress further in meiosis and germline development. In this model, as in C. elegans, the observed sexual dimorphism is not due to variations in the stringency of a meiotic checkpoint but is the result of differences in the outcome of its activation. Furthermore, this interpretation suggests that there may be a greater investment in attempting to salvage the single oogenic product by promoting repair pathways to correct recombination defects, as opposed to simply removing damaged oocytes.
This model makes the prediction that checkpoint-activating mutations will exhibit more severe responses during oogenesis when combined with a mutation in a DNA damage checkpoint component required for repair. Unfortunately, DNA damage checkpoint components, such as Hus1, ATR and Chk1, are essential in mice [13] [14] [15] , making these experiments dependent on conditional knockdowns. However, the characterization of ATM kinase (Ataxia-telangiectasia, mutated) may support this idea. ATM is also a sensor for DNA damage, particularly in response to double strand breaks [7] . Mice in which this gene has been mutated are viable but infertile [16, 17] , indicating that ATM participates in meiotic recombination [18] . Most importantly, these mutant mice do not appear to exhibit sexual dimorphism in response to their defects: Germ cells undergo apoptosis in early prophase during both oogenesis and spermatogenesis [19] . Given that ATM is required for meiotic recombination, dissecting its role in monitoring DNA damage during meiosis may be problematic. Yet, epistasis experiments between ATM and checkpoint-activating mutations in female mice could prove informative in determining the relative contributions of repair versus removal during the checkpoint response in mammalian oogenesis. Figure 1 . The DNA damage checkpoint responds to meiotic recombination defects in both males and hermaphrodites in C. elegans. In hermaphrodites undergoing oogenesis, defects in meiotic recombination recruit proteins that monitor DNA damage (HUS-1 and ATL-1) and signal to downstream effectors (such as CHK-1), activating both the repair and apoptotic pathways. In males undergoing spermatogenesis, the same sensor proteins are recruited to sites of damage and signal to the repair and apoptotic pathways. However, apoptosis does not occur in response to meiotic defects in males due to an inability to activate CED-3, which is expressed in the male germline.
Genes underlying the evolution of morphological traits have recently been identified in a number of model species. In the stickleback, the metabolic adaptations to a freshwater habitat have now been linked to a well-known hormonal system.
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The genetic basis of phenotypic diversity is one of the most challenging questions in biology and, of course, is of particular significance during 2010, the international year of biodiversity [1, 2] . Thanks to the new possibilities provided by comparative genome-wide analysis and also to the development of adequate biological models, recent progress has been made in this area. The genes underlying phenotypic traits have recently been uncovered in a number of different plants and animal models, and this has considerably increased our understanding of the genomic targets of evolution [3] . Up to now, most of these cases were linked to morphological traits (e.g., pelvic spine reduction in sticklebacks, trichome patterns in Drosophila, kernel size in maize) or to changes in pigmentation (albinism in cavefish, wing colour pattern in Drosophila species) [3] . However, in this issue of Current Biology, Kitano et al. [4] use the stickleback model to study a phenotype linked not to a morphological trait but to a physiological adaptation.
Interestingly, the signalling pathway targeted in this adaptation is a well-known hormonal system, the thyroid hormone signalling pathway, that is known to regulate many aspects of post-embryonic development in vertebrates, including metabolism. The threespine stickleback (Gasterosteus aculeatus) is a marine fish that lives in coastal waters. Since the end of the last glacial period there have been several independent events resulting in this species becoming isolated in freshwater habitats [5, 6] (Figure 1 ). These events have been accompanied by dramatic morphological and physiological changes, and have led to the large phenotypic diversity observed in this species in the northern hemisphere. Different populations exhibit pronounced alteration in body size, number and pattern of lateral plates, development of pelvic fins, etc. The variations within these populations provide a unique opportunity to identify genes implicated in natural adaptations, even if the adaptive value of some of these traits is still under discussion [7] . The stickleback offers a particularly favourable case since the various freshwater isolates are relatively recent (less than 10,000-15,000 years), and thus crosses between marine and freshwater populations are fertile, allowing genetic analyses to be performed. Indeed, in recent years, quantitative trait loci (QTL) analyses have been used to identify specific genes linked to various adaptations. In some cases, the specific change at the genomic level 
